Ran Zheng
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Ran Zheng is currently an Independent Director at Caribou Biosciences, Inc. since 2021.
Former roles include Chief Executive Officer & Director at Landmark Bio PBLLC from 2021 to 2025, Vice President-Development Supply Chain at Amgen, Inc., and Chief Technical Officer at Orchard Therapeutics Plc from 2019 to 2021.
Education includes graduate studies at the University of Minnesota and undergraduate studies at Beijing Forestry University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Directeur/Membre du Conseil | 24/09/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Landmark Bio PBLLC
Landmark Bio PBLLC BiotechnologyHealth Technology Manufactures and develops cell & gene therapy products | Directeur Général | 01/01/2025 |
| ORCHARD THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 01/02/2021 |
| AMGEN INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beijing Forestry University
Beijing Forestry University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Landmark Bio PBLLC
Landmark Bio PBLLC BiotechnologyHealth Technology Manufactures and develops cell & gene therapy products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national